News
CEGX presents sequencing technology at Biology of Genomes 2022
CEGX scientists discussed novel technology at genomics conference in Cold Spring Harbour Laboratory
CEGX scientists discussed novel technology at genomics conference in Cold Spring Harbour Laboratory
CAMBRIDGE, United Kingdom, Nov. 02, 2021 — Cambridge Epigenetix (CEGX), a life sciences tools and technology company revolutionizing genome sequencing, today announced the signing of
Epigenetics, the misunderstood science that could shed new light on ageing
Sir Shankar Balasubramanian, inventor of Next Generation DNA Sequencing (NGS)
The award-winning researcher behind next generation sequencing (NGS)
Google Ventures leads $21M Series B in bioscience company Cambridge Epigenetix